Why Does Metformin Deplete B12, And Why Did Nobody Tell You?

How Metformin Depletes B12

Vitamin B12 absorption in the gut requires a specific mechanism involving a protein called intrinsic factor and calcium dependent receptors in the terminal ileum, the last section of the small intestine. Metformin interferes with this calcium dependent absorption mechanism, reducing the amount of B12 the intestine can absorb from food and from oral supplements that rely on the same pathway.

The effect is dose dependent, higher metformin doses cause greater B12 reduction, and cumulative over time. Studies have shown that metformin use is associated with B12 deficiency in approximately 10 to 30 percent of patients on long term therapy, with deficiency rates increasing with duration of use.

Why This Matters Clinically

Vitamin B12 is essential for the production of myelin, the protective sheath around nerve fibers, and for the synthesis of red blood cells and DNA. B12 deficiency produces a range of clinical consequences that develop gradually and insidiously:

Peripheral neuropathy. Numbness, tingling, burning pain, and weakness in the hands and feet, symptoms that are strikingly similar to diabetic neuropathy. A patient on metformin who develops these symptoms may be told they have diabetic neuropathy and have their diabetes medications adjusted, when the actual cause is B12 depletion from the metformin itself.

Anemia. B12 deficiency causes megaloblastic anemia, a condition where red blood cells are abnormally large and dysfunctional. Symptoms include fatigue, weakness, shortness of breath, and pallor.

Cognitive impairment. B12 deficiency is associated with memory problems, difficulty concentrating, mood changes, and in severe cases dementia like symptoms. In elderly patients on long term metformin this is a particularly significant concern because cognitive changes may be attributed to aging rather than a correctable nutrient deficiency.

Elevated homocysteine. B12 is required for the metabolism of homocysteine, an amino acid that at elevated levels is associated with increased cardiovascular risk. B12 deficiency leads to homocysteine accumulation, creating an additional cardiovascular risk factor in a population, diabetic patients, that already carries elevated cardiovascular risk.

The Misdiagnosis Problem

The most clinically consequential aspect of metformin induced B12 depletion is how often the resulting neuropathy is misdiagnosed.

A diabetic patient who develops peripheral neuropathy is most likely to have that neuropathy attributed to their diabetes, because diabetic neuropathy is common, well recognized, and the obvious differential diagnosis. The question of whether the neuropathy might be B12 related, caused by the medication used to treat the diabetes, requires a B12 level to be checked, a step that is often not taken.

The practical consequence is patients receiving treatments for diabetic neuropathy, which is not fully reversible, when they actually have B12 deficiency neuropathy, which is potentially reversible with B12 supplementation if caught early enough.

What the Guidelines Say

The American Diabetes Association has included monitoring of B12 levels in patients on long term metformin as a recommended clinical practice for years. The recommendation is to check B12 levels periodically, typically every one to two years for patients on long term metformin therapy.

Despite this guideline recommendation, B12 monitoring in metformin patients remains inconsistently practiced in primary care. The appointment time constraints we have discussed throughout this series mean that monitoring recommendations that are not automated or prompted by the electronic medical record are frequently deprioritized.

What You Should Do

If you are currently taking metformin: Ask your physician or pharmacist when your B12 level was last checked. If it has not been checked within the past year, or has never been checked, request a B12 level at your next blood draw.

If your B12 level is low or low normal: Supplementation with methylcobalamin, the active, methylated form of B12 that does not rely on the same absorption pathway that metformin disrupts, is typically recommended. Standard cyanocobalamin supplements may have reduced efficacy in metformin patients because they require conversion by the same mechanisms metformin impairs. Methylcobalamin bypasses this problem.

If you have symptoms of neuropathy: Numbness, tingling, or burning in your hands or feet that has developed or worsened since starting metformin should be specifically discussed with your physician in the context of B12 status, not just attributed to diabetes without a B12 level being checked.

If you are a family member of someone on long term metformin: This post is worth sharing with them. The conversation about B12 monitoring takes about two minutes and can prevent a progressive neurological condition.

This article is for general information only and is not a substitute for personalized medical advice. Before starting or changing any medication, including over the counter products and supplements, talk with your pharmacist or physician about your specific situation.